RASONQUE
NDC 85219-104, daraxonrasib, tablet, film coated, from Revolution Medicines, Inc..
- Product NDC
- 85219-104
- Status
- Listed
- Labeler
- Revolution Medicines, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220910
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85219-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DARAXONRASIB150 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85219-104-01 | 85219010401 | 1 BOTTLE in 1 CARTON (85219-104-01) / 30 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/13a65923-d072-4dac-8620-8eabbf8c3641
Use it
Look up 85219-104 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85219-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85219-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.